Levosert® is now licensed for 4 years use for contraception and heavy menstrual bleeding
Posted 12 March 2018
Date: 12 Mar 2018
Type: FSRH News and Information
Levosert licensing update
Levosert (20mcg/24 hours) Intrauterine Delivery System (Levonorgesterel 52mg) is indicated for contraception and treatment of heavy menstrual bleeding. Licensed for 3 year use since its launch in the UK in early 2015, Levosert has now been approved in the UK for 4 years use.
This means that any existing women who have Levosert may keep their levosert IUS for 4 years from the date of the insertion as the product is exactly the same as it was previously when licenced for 3 years.
The updated Summary of Product Characteristics for Levosert notes that “Levosert should be removed after 4 years from the date of insertion”.
FSRH new product reviews for Levosert and Kyleena® has been updated to reflect the extended license period.
The product review can be downloaded below this news story.